ReTaMed ApS: Financial statements 2024
CVR: 39608405
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ReTaMed ApS (CVR 39608405) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -861 compared with DKK -7,846 the year before. Equity in the 2024 report amounted to DKK 100,577. The solvency ratio was 45.1%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -861
- Equity
- DKK 100,577
- Total Assets
- DKK 223,032
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | -861 | 101 t. | - |
| 2023 | - | -14 t. | -8 t. | 101 t. | - |
| 2022 | - | -18 t. | -13 t. | 108 t. | 0 |
| 2021 | - | -60 t. | -57 t. | 121 t. | 1 |
| 2020 | - | 350 t. | -238 t. | 178 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ReTaMed ApS has published its annual report for 2023. Gross profit came to DKK -13,795, and the net result was DKK -7,846.
About ReTaMed ApS
ReTaMed ApS is a Danish company of the type Anpartsselskab based in Esbjerg, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Henrik Fomsgaard-Knudsen. The company is owned by ReTaMed Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,022 compared with DKK -861 the year before. Equity in the 2025 report amounted to DKK 50,000.